about
The relationship between nutrition and prostate cancer: is more always better?The importance of LDL and cholesterol metabolism for prostate epithelial cell growthCholesterol biosynthesis inhibitor RO 48-8071 suppresses growth of hormone-dependent and castration-resistant prostate cancer cellsInduction of erythroid differentiation in human erythroleukemia cells by depletion of malic enzyme 2Cholesterol and benign prostate disease.Metabolomic characterization of human prostate cancer bone metastases reveals increased levels of cholesterol.Hypercholesterolemia induces angiogenesis and accelerates growth of breast tumors in vivo.Impact of circulating cholesterol levels on growth and intratumoral androgen concentration of prostate tumorsThe response of the prostate to circulating cholesterol: activating transcription factor 3 (ATF3) as a prominent node in a cholesterol-sensing networkThe expanding role of marine microbes in pharmaceutical development.Aging-related alterations in the extracellular matrix modulate the microenvironment and influence tumor progression.Role of cholesterol in the development and progression of breast cancerThe complex interplay between cholesterol and prostate malignancy.Activation of androgen receptor, lipogenesis, and oxidative stress converged by SREBP-1 is responsible for regulating growth and progression of prostate cancer cells.Hypercholesterolemia promotes an osteoporotic phenotype.A high-fat diet containing whole walnuts (Juglans regia) reduces tumour size and growth along with plasma insulin-like growth factor 1 in the transgenic adenocarcinoma of the mouse prostate model.Ezetimibe/simvastatin.Scavenger receptor class B type I regulates cellular cholesterol metabolism and cell signaling associated with breast cancer development.The role of cholesterol metabolism and cholesterol transport in carcinogenesis: a review of scientific findings, relevant to future cancer therapeutics.Diet-induced hypercholesterolemia promotes androgen-independent prostate cancer metastasis via IQGAP1 and caveolin-1Evidence for Feedback Regulation Following Cholesterol Lowering Therapy in a Prostate Cancer Xenograft Model.The Role of Cholesterol in Cancer.Words of wisdom. Re: Dysregulation of cholesterol homeostasis in human prostate cancer through loss of ABCA1.Cholesterol Metabolism and Prostate Cancer Lethality.Marketed drugs used for the management of hypercholesterolemia as anticancer armament.A Western-type diet accelerates tumor progression in an autochthonous mouse model of prostate cancer.Cholesterol and prostate cancer.The Rafts of the Medusa: cholesterol targeting in cancer therapy.Serum cholesterol and risk of high-grade prostate cancer: results from the REDUCE study.Pharmacological blockade of cholesterol trafficking by cepharanthine in endothelial cells suppresses angiogenesis and tumor growth.Using genetics to explore whether the cholesterol-lowering drug ezetimibe may cause an increased risk of cancer.
P2860
Q24604956-74E65D7C-5B3B-4564-ABD9-8F4FF7A8953FQ28727920-06EB7C7A-DA42-4A1C-BD33-E4A193804C04Q28829206-E860229B-1215-4EC8-9EA0-75F8F7FDBF75Q33686871-09F728BA-19C8-4F5A-BB1D-C0881CF6C2D5Q33732687-CB5270ED-16BD-4565-8271-C713F35DB588Q33769607-D3FDB640-A4F4-4EA5-B2EF-98985511A6C7Q33826605-6BCE0FE2-6231-4FE4-9CCA-22ADD92079BFQ34141720-E6514731-47A0-4022-A43C-C720A3C038B5Q34328954-25155925-188A-4306-AD02-1D9BA807422DQ34362843-7DC23E75-3673-4C2E-8A17-6508A8F651EAQ34507732-289EC9DF-5A28-4F37-BBB1-B338AAC459ECQ34755686-682562AA-2801-4076-90F0-016AACCFD739Q35137013-DF09A2FF-C9E0-4B36-9F22-7AD5CA6535C6Q35683332-62FF358C-FAB5-4775-AA31-38892591EE39Q36204181-1237C020-EBC0-4F9F-AA9E-27A27A30D254Q36443123-7ACE6EF0-CBD3-441D-B59C-DACEBD3E024DQ37646768-6BA32721-0B55-4FD4-834D-A4E544D00C30Q37690024-81A98CF0-08F1-4ABF-BA3C-7B6D4FE3F67CQ38149124-2AF84E1F-B243-4C21-822D-246829BD4109Q38426514-0311E76C-67B4-4717-8839-210DDDB8381EQ38728309-98964BC3-65C2-411A-8909-7D54CC384315Q38838555-1C1A7BBB-59F6-4709-9D09-A92E6AAEF298Q40506789-E489D81A-5B45-4511-BE15-FBF7531644D7Q40690119-7DB91B5D-D0CC-4DA7-890B-424B0201BD1AQ41080847-36A76401-96C8-45D7-985E-B134DDAB8778Q41460209-E90903D3-4F82-484D-BED5-66654CE5EDB7Q42079833-6198FDBE-7410-408E-AB1C-D2D0A63EE2C6Q43075201-F9A95E67-1D20-4868-A538-929E10938452Q47241309-4115796C-8299-4E29-A170-3EA239C4C283Q47783148-C1B7F4FF-188C-4E95-A032-82D0A9E96269Q50140841-735A5E3B-91AA-4F86-885D-DD1CFF6ED8CB
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Ezetimibe is an inhibitor of tumor angiogenesis.
@en
Ezetimibe is an inhibitor of tumor angiogenesis.
@nl
type
label
Ezetimibe is an inhibitor of tumor angiogenesis.
@en
Ezetimibe is an inhibitor of tumor angiogenesis.
@nl
prefLabel
Ezetimibe is an inhibitor of tumor angiogenesis.
@en
Ezetimibe is an inhibitor of tumor angiogenesis.
@nl
P2093
P2860
P1476
Ezetimibe is an inhibitor of tumor angiogenesis.
@en
P2093
Carl P Schaffner
Christopher Tully
Jayoung Kim
Jinsoo Joo
Keith R Solomon
Kelly Boucher
Kristine Pelton
Michael R Freeman
P2860
P304
P356
10.2353/AJPATH.2009.080551
P407
P577
2009-01-29T00:00:00Z